Summit joins the global colorectal fight
The pivotal Harmoni-GI3 study has started enrolling patients.
HengRui goes pivotal in KRAS G12D
The group will take HRS-4642 into a Chinese phase 3 in first-line pancreatic cancer.
After SpringWorks, Immunome has a Ringside seat
Varegacestat’s pivotal study reads out imminently.
BioNTech’s big gotistobart day approaches
Readout of the Preserve-003 trial in post-PD-(L)1 NSCLC is due in December.
The month ahead: December’s upcoming events
ASH and SABCS approach.
ASH 2025 preview – toxicity worries hit BeOne’s sonrotoclax
The project has priority review, but deaths could raise eyebrows.
Kivu and Menarini against the odds
New first-in-human trials include Kivu and Menarini projects acting on PKT7 and KIF18A.
